Filter Options
Required*
Filter
Cambridge / Massachusetts / United States
0.0
Merrimack Pharmaceuticals is a privately held integrated biotechnology company. The company is dedicated to the discovery and development of therapies for the treatment of autoimmune disease and cancer. Its goal is to provide patients and physicians with some of the best possible treatments and support its pharmaceuticals with the tools to enable the prescription of the right drug for the right patient. The company is advancing a pipeline of clinical and early-stage biologics that represent patient-directed, targeted therapies. Its discovery and development efforts are founded on its proprietary Network Biology research engine. Its lead product, MM-093, is in clinical trials for the treatment of patients with rheumatoid arthritis and psoriasis. Merrimack Pharmaceuticals is based in Cambridge, Mass.
Cambridge / Massachusetts / United States
0.0
In operation since 1981, Genzyme Corporation is one of the leading biotechnology companies in the world. The company employs a staff of more than 12,000 people and manages over 85 locations in nearly 40 countries. It focuses on the areas of hematologic oncology, biosurgery, transplant, genetic diseases, and cardiometabolic and renal. Genzyme Corporation offers Fabrazyme, which is a solution for intravenous infusion. The company also provides Fabrazyme, Renagel, Renvela and Hectorol. It offers solutions for the medical and patient communities. In addition, Genzyme Corporation offers Synvisc, which is a viscosupplementation treatment for relieving knee pain associated with osteoarthritis. The company provides Sepra, which is a line of hyaluronic acid-based products.